TRMED — Thor Medical ASA Share News
0.000.00%
Last trade - 00:00- NOK1.60bn
- NOK1.78bn
- NOK0.44m
Brief: Nordic Nanovector Awarded NOK 12 Million In Funding From The Norwegian Research Council
Brief: Nordic Nanovector Provides Update On Lymrit 37-05 Phase 1 DLBCL Trial
Brief: Nordic Nanovector: New Preclinical Data Offer Insights Into Enhancing Betalutin-Based Therapies In NHL
Europe Research Roundup: Epiroc, IMI, Johnson Matthey
Brief: Nordic Nanovector Q3 Comprehensive Loss Widens To NOK 93.6 Million
Brief: Nordic Nanovector Resolves Not To Proceed With Repair Offering
Brief: Nordic Nanovector Raises NOK 242.5 Mln Through Private Placement
Brief: Nordic Nanovector Launches Private Placement Of New Shares
Brief: Nordic Nanovector Signs Global Clinical And Commercial Agreement With ITM
Europe Research Roundup: Aviva, Beiersdorf AG, Weir Group
Brief: Nordic Nanovector: Updates On Several Programs
Brief: Nordic Nanovector Q2 Comprehensive Loss Widens To NOK 110.4 Mln
Brief: Nordic Nanovector Q2 Total Operating Expenses At NOK 111.0 Mln
Brief: Nordic Nanovector Completes Patient Enrolment In Phase 1 Trial Of Betalutin In Diffuse Large B-Cell Lymphoma
Brief: Nordic Nanovector To Present Preclinical Studies With 212PB-NNV003
Brief: Nordic Nanovector Gets European Patent
Brief: Nordic Nanovector Q1 Comprehensive Loss Widens To NOK 91.6 Million
Brief: Nordic Nanovector: Results From Preclinical Studies With Novel Cd37-Targeted Alpha Therapy
Brief: Nordic Nanovector Says Commencement Of Repair Offering Of Up To 777,777 Shares With Par Value Of Nok 0.20 Each At Price Of NOK 45.00 Per Offer Share